Acorda Therapeutics, Inc.
-
Ticker
ACOR
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Ardsley, New York
Acorda Therapeutics, Inc., a commercial stage biopharmaceutical company, involves in the identification, development, and commercialization of therapies for multiple sclerosis (MS), spinal cord injury, and other nervous system disorders.
REPORT RATINGS
4.7 / 5.0 (158)
Acorda Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 158 reviews.
Acorda Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports